Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ocular graft vs. host disease.

¹Section of Ophthalmology, Department of Head and Neck Surgery, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA. skim@mdanderson.org

The Ocular Surface

|January 12, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multicenter Interspecialty Consensus on Experimental Oncology Drug-Related Ocular Adverse Event Reporting.

JAMA ophthalmology·2025

Same author

A Phase 3b Study for Management of Ocular Side Effects in Patients with Epidermal Growth Factor Receptor-Amplified Glioblastoma Receiving Depatuxizumab Mafodotin.

Ophthalmic research·2023

Same author

Mitigation and management strategies for ocular events associated with tisotumab vedotin.

Gynecologic oncology·2022

Same author

Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022

Same author

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2020

Same author

Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine.

Clinical cancer research : an official journal of the American Association for Cancer Research·2018

Acute graft-versus-host disease (GVHD) involves Th1 inflammation, while chronic GVHD involves Th2 inflammation. Understanding ocular GVHD

Area of Science:

Immunology
Ophthalmology
Transplantation

Background:

Acute graft-versus-host disease (GVHD) is primarily considered a Th1 inflammatory process.
Chronic GVHD is characterized by Th2-mediated inflammation.
Ocular GVHD presents unique challenges in understanding its pathophysiology.

Purpose of the Study:

To explore the pathophysiologic links between systemic and ocular GVHD.
To identify new strategies for preventing and treating ocular GVHD.
To further elucidate the inflammatory profile of ocular GVHD.

Main Methods:

The abstract does not specify methods.
Further studies are ongoing to understand the inflammatory profile.

Main Results:

Related Experiment Videos

The abstract does not specify results.
Current understanding suggests distinct inflammatory profiles for acute and chronic GVHD.

Conclusions:

Acute and chronic GVHD involve different inflammatory pathways (Th1 vs. Th2).
Understanding these pathways is crucial for developing ocular GVHD treatments.
Ocular GVHD is a complex disorder requiring further investigation.